Limitations of Sniff Nasal Pressure as an Outcome Measurement in Amyotrophic Lateral Sclerosis Patients in a Clinical Trial

Abstract

The delayed decline in SNIP measurements suggests a learning effect over time. The optimal number of SNIPs in ALS clinical trials has yet to be determined. SNIP measures should be used with caution in trials with a lead-in design.